The FDA has even accredited a drug built with cannabidiol for that intent (Epidiolex). Nevertheless the company only recommends it for two rare types of childhood epilepsy termed Lennox-Gastaut syndrome and Dravet syndrome. In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they pl